Related content

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 226-230

Spandidos Publications

Access to resources Recommend Favorite

Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases

By Song Zhengbo   Zhang Yiping  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-4

Humana Press, Inc

Access to resources Recommend Favorite

Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma

By Ramankulov Azizbek   Lein Michael   Kristiansen Glen   Meyer Hellmuth-A.   Loening Stefan   Jung Klaus  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 643-652

Springer Publishing Company

Access to resources Recommend Favorite

Solitary breast metastases from a renal cell carcinoma

By Vassalli L.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 29-31

Springer Publishing Company

Access to resources Recommend Favorite